Gaudium IVF and Women Health Ltd reports Q2 FY27 consolidated revenue of ₹37.41 crore and net profit of ₹9.41 crore
- Revenue rose 93.1% sequentially and 17.9% year on year; net profit increased 430.3% sequentially and 0.4% year on year.
- Estimated EBITDA margin was 36.0%; auditors issued an unmodified limited-review conclusion. Q2 FY26 comparative figures were not reviewed.
- Board approved proposed changes to six locations and the establishment schedule for 19 IPO-funded IVF centres; the ₹50 crore allocation is unchanged, with completion planned by FY29, subject to shareholder approval.
- Dr. Ravish Manchanda was appointed National Head – Operations Expansion & Strategy.
